028: Ascorbic acid prevents contrast-mediated nephropathy in patients undergoing coronary angiography  by Hamdi, Sonia et al.
© Elsevier Masson SAS. All rights reserved.
 
10 Archives of Cardiovascular Diseases Supplements (2013) 5, 1-18
Results: In univariate analysis : The only significant variables between the
02 groups are: age, diabetes, smoking, clearance of creat.
In multivariate analysis, two significant variables: diabetes, the creatinine
clearance.
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Background: Radiocontrast nephropathy is associated with increased mor-
bidity and mortality, particularly in patients with percutaneous coronary inter-
ventions. A number of agents that improve renal circulation have been
clinically tested for prevention of radiocontrast nephropathy, but none of them
has succeeded. Protection of renal tubular cells against oxidative stress is
another approach to avoid radiocontrast nephropathy. Prophylactic effects of
antioxidants such as N-acetylcysteine have been reported by several investiga-
tors, although the effectiveness of these compounds is still a matter of debate.
Ascorbic acid, an antioxidant agent, a safe and not expensive medication,
could be used to prevent radiocontrast nephropathy.
Methods: We conducted a randomized, double-blind, placebo-controlled
trial of ascorbic acid in 202 patients who underwent coronary angiography
and/or intervention. The patients were randomly assigned to receive either oral
Vitamin C (3 g at least 2 hours before the procedure and 2 g in the night and
the morning after the procedure) or placebo, in adjunct to hydration. Serum
creatinine was measured prior to and 48h after coronary angiography. The pri-
mary end-point was the occurrence of CIN, defined as an increase in serum
creatinine ≥0.5 mg/dL (44.2 μmol/L) or ≥25% above baseline at 48h after
exposure to contrast medium.
Results: Complete data on the outcomes were available on 202 patients,
107 of whom had received Vitamine C. There were no significant differences
between the Vitamin C and placebo groups in baseline characteristics, amount
of hydration, or type and volume of contrast used. CIN occurred in 11 out of
107 (10.3%) patients in the Vitamin C group and 20 out of 95 (21.1%)
patients in the placebo group (P=0.032).
Conclusion: There was detectable benefit for the prophylactic administra-
tion of oral Vitamin C over an aggressive hydration protocol in patients
Undergoing Coronary Angiography or Intervention.
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Background: A common argument for identifying SMI in asymptomatic
diabetic patients is to intensify treatment of risk factors and to propose a cor-
onarography for eventual revascularization. However, published data demon-
strating that a prospectively applied screening program improves outcome in
asymptomatic diabetic patient are still lacking.
Aim: Our objective was to determine if patients with SMI+ and coronar-
ography have a better survival than the patients with SMI who did not undergo
coronagraphy.
Methods and results: In our department, we used to screen for SMI in high
risk diabetic patients, following international recommendations. All patients
benefit of treatment of their risk factors following international guidelines.
Since 2000, 913 high risk diabetic patients with normal baseline electro-
cardiography were evaluated to identify patients with SMI, using myocardial
perfusion imaging. SMI prevalence was 18%. Coronarography was done in
94 patients SMI+. There was no difference regarding risk factors between the
group who underwent coronarography and the one who did not. These patients
were followed during a mean period of 6,5 years. Survival analysis was made
for univariate analysis, using Kaplan Meyer methods. Covariables with p-
value < 0.15 at log-rank test were introduced in COX multivariate analysis.
Significant variables were selectioned for final model selection through STEP-
WISE, BACKWARD, FORWARD methods.
79 patients died (8,6%), mainly from cardiovascular diseases (84%). In
univariate analysis, presence of SMI was not associated with total mortality
(p=0,2263) nor cardiovascular mortality (p=0,57). Furthermore, in the group
of patients SMI+, coronarography was not associated with a better survival in
multivariate analysis.
Conclusion: This observational study should argue for intensive cardiovas-
cular risk factors treatment in diabetes in reducing cardiovascular mortality,
with no argument for a benefit from SMI screening
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Background: We investigate the frequency, correlates, and clinical signif-
icance of bleeding complications in diabetic patients (pts) with long-term dual
antiplatelet treatment (DAPLT) after drug-eluting stent (DES) implantation.
Methods: We assessed 610 consecutive diabetic pts (male 80%, mean age















Effect Criteria effect model fit 
tests likelihood ratios
Likelihood ratios tests
2 Log likelihood 




Constante 92.885 (a) .000 0 .
Smoking 93.919 1.034 1 0.309
Diabetes 97.049 4.164 1 0.041
Age group 99.702 6.817 6 0.338
cclear 100.610 7.725 2 0.021
Type sca 94.859 1.974 1 0.160
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